Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.1M | 9.1M | 4.4M | 34.1M |
| Cost of revenue | 405K | 408K | -6.6M | 9.5M |
| Gross profit | 7.7M | 8.6M | 11.0M | 24.6M |
| Operating expense | ||||
| Research & development | 290.3M | 253.9M | 263.5M | 211.5M |
| Selling general and admin | 102.8M | -20.8M | 93.8M | 80.8M |
| Other operating expenses | 21.6M | — | 3.1M | — |
| Operating income | -407.0M | -396.1M | -349.4M | -267.7M |
| Non operating interest income | ||||
| Income | 41.6M | 62.6M | 68.5M | 31.2M |
| Expense | 7.7M | 8.3M | 8.8M | 57.5M |
| Other income expense | — | — | — | — |
| Pretax income | -336.7M | -291.6M | -267.8M | -294.1M |
| Tax provision | -1.4M | -574K | -1.4M | -1.3M |
| Net income | -335.3M | -291.0M | -266.4M | -292.8M |
| Basic EPS | -4.8 | — | -3.8 | -4.7 |
| Diluted EPS | -4.8 | — | -3.8 | -4.7 |
| Basic average shares | 470.2M | — | 470.6M | 417.5M |
| Diluted average shares | 470.2M | — | 470.6M | 417.5M |
| EBITDA | -371.8M | -306.6M | -291.0M | -229.8M |
| Net income from continuing op. | -335.3M | -291.0M | -266.4M | -292.8M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |